Diabetes UK launches new peer support service
April 16, 2012Diabetes UK, diabetes, peer support
Diabetes UK has launched a new support service that puts people with diabetes in touch with others who have the …
Senior team moves at ROCK medical communications
April 16, 2012Business Services, Medical Communications, Sales and Marketing Rock Medical Communications
ROCK medical communications has appointed Eric Hansen as director and promoted Clare Pressney to associate director. Most recently Hansen spent …
MSI appoints new partner
April 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, Sanofi, appointment
Pharma consultancy firm MSI has announced the appointment of a new partner. Steve Mather takes up this senior position with …
UK government invests in new radiotherapy treatment
April 16, 2012Sales and Marketing Cancer, Photon beam therapy, Proton beam therapy, prostate cancer, radiotherapy
The government is to invest £250 million in a cutting-edge radiotherapy treatment that should benefit 1,500 cancer patients in the …
Cloud computing ‘eagerly anticipated’ by healthcare
April 16, 2012Medical Communications, Sales and Marketing Cloud Computing, digital, healthcare
The use of cloud computing in healthcare is expected to grow significantly in the coming years, but developed countries may …
Takeda to buy gout specialist URL Pharma for $800m
April 16, 2012Research and Development, Sales and Marketing R&D, Takeda, acquisition, gout
Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid. …
Access to new cancer drugs limited in Brazil and Mexico
April 13, 2012Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets
Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …
Januvia gains renal impairment licence in UK
April 13, 2012Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment
Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …
UCB launches ‘Parkinson’s Well-Being Map’
April 13, 2012Medical Communications Parkinson's disease, UCB
UCB has launched a new visual tool to help people with Parkinson’s Disease to discuss their health and symptoms with …
Innovating in China’s pharma market
April 12, 2012Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets
The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …
ViiV Healthcare appoints Just:: Health PR
April 12, 2012Medical Communications, Sales and Marketing HIV/AIDS, Just::, PR, ViiV
ViiV Healthcare has appointed Just:: Health PR to work on an integrated political and public relations initiative that will engage …
Roche on target despite European shrinkage
April 12, 2012Sales and Marketing Illumina, Q1 2012, Roche
Roche saw its business grow in the first three months of the year, thanks to strong showings from hepatitis C …
EMA backs full access to trial data
April 12, 2012Business Services, Research and Development, Sales and Marketing EMA, clinical trial data, data disclosure, regulatory affairs, transparency
The European Medicines Agency says it wants to open up access to full clinical trial data, but warns that some …
immatics appoints Dr Rainer Kramer as its new
 chief business officer
April 12, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
immatics biotechnologies, a biopharma company developing therapeutic cancer vaccines, has appointment Dr Rainer Kramer as its new chief business officer. …
Algeta to co-promote Alpharadin in US
April 12, 2012Sales and Marketing Algeta, Bayer, prostate cancer
Algeta has exercised its option to co-promote Alpharadin for the treatment of cancer patients with bone metastases in the United …
Humira gains European licence for ulcerative colitis
April 11, 2012Sales and Marketing Humira, ulcerative colitis
Abbott’s Humira has gained European approval to treat ulcerative colitis, adding to its six existing licences. It can now …
UK launches ‘biomedical catalyst’ fund
April 11, 2012Biotechnology, SMEs, biomedical catalyst, strategy for life sciences
A £180 million government fund to help innovative small and medium sized enterprises (SMEs) and academics to develop solutions to …
Amgen to acquire kidney disease specialist for $315m
April 11, 2012Sales and Marketing Amgen, KAI Pharmaceuticals
Amgen will acquire KAI Pharmaceuticals for $315 million to bolster its late-stage pipeline. The deal, which should be completed within …
A more ‘nimble approach’ needed for CRO-pharma partnerships
April 10, 2012Research and Development CRO, partnerships
Pharma firms need to create closer and more flexible relationships with their contract research organisations for better outcomes. This is …
J&J unveils plans to boost Doxil supplies
April 10, 2012Manufacturing and Production Ben Venue, Doxil, J&J, JJ, drug shortages
Johnson & Johnson is planning to transfer filling and packaging of Doxil to another supplier in an attempt to alleviate …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
